Old Web
English
Sign In
Acemap
>
authorDetail
>
Daniel R. Stellato
Daniel R. Stellato
Oncology
Internal medicine
Medicine
Chronic phase chronic myeloid leukemia
in patient
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective
2019
Journal of Medical Economics
Margaret E. Gerbasi
Daniel R. Stellato
Sameer R. Ghate
Briana Ndife
Aaron Moynahan
Dinesh Mishra
P Gunda
Roy Koruth
Thomas E. Delea
Show All
Source
Cite
Save
Citations (7)
Survival Outcomes in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Receiving Third- or Subsequent Line (3L) Treatment
2017
Clinical Lymphoma, Myeloma & Leukemia
Daniel R. Stellato
Lisa McGarry
Hui Huang
Shaina Hastings
Thomas E. Delea
Jeffrey H. Lipton
Show All
Source
Cite
Save
Citations (0)
1